In a record-breaking real estate transaction, Adar Poonawalla, the CEO of Serum Institute (SII), has secured the title for the most expensive home sale of the year. His acquisition is a multi-million-pound mansion in London's prestigious Mayfair area, with a reported value of approximately Rs 1446 crore, as noted by the Financial Times. This 25,000 square foot residence, situated near Hyde Park, stands as the epitome of luxury and holds the distinction of being the priciest house of 2023. Notably, this historic property, dating back nearly a century to the 1920s, is a significant addition to Adar Poonawalla's assets.
The mansion's purchase involves Adar Poonawalla acquiring it from Dominika Kulczyk, the daughter of the late Polish businessman Jan Kulczyk. In addition to the main residence, Serum Life Sciences, a British subsidiary of SII will be acquiring the purchase Including a connecting guest house that provides exclusive access to one of Mayfair's hidden gardens. Remarkably, this transaction marks the second-highest residential property sale ever and the biggest deal of the year recorded in London's history.
Poonawalla states his plan for the mansion, making it clear that a permanent move to London is not on the agenda. The mansion will primarily serve as a space for family visits to the UK and as a company base. The Aberconway House, included in the acquisition, is designated to serve as a corporate guest house and will also play a pivotal role in hosting events, fostering partnerships, and extending a warm welcome to donors. This strategic decision will not only strengthen the Serum Group's global standing but will also create new opportunities for the company and eliminate room for certain challenges.
Presently, Poonawalla resides in the prestigious Lincoln House, an iconic mansion valued at 750 crores. Originally acquired in September 2015 by Cyrus Poonawalla for US $113 million, this residence holds significant historical and monetary value.
Poonawalla joined the Serum Institute in 2001 and ascended to the position of CEO in 2011, contributing significantly to the institute's success. The Serum Institute of India, a family-owned business, has thrived, particularly gaining prominence for its pivotal role during the COVID-19 pandemic. Recognized as the world's largest vaccine manufacturer, the institute produced cost-effective inoculations for developing nations, a feat unmatched by other companies. Their vaccines, developed by AstraZeneca and Oxford University, played a crucial role in vaccinating millions of people worldwide.
